| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Veerle Gobin, Katleen Van Steendam, Sabine Fevery, Kelly Tilleman, An D Billiau, Damiaan Denys, Dieter L Deforc. Fluoxetine reduces murine graft-versus-host disease by induction of T cell immunosuppression. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 8. issue 4. 2014-04-11. PMID:23640520. |
serotonin reuptake inhibitors (sris) are widely used drugs in the treatment of depression and anxiety disorders. |
2014-04-11 |
2023-08-12 |
human |
| Maarika Liik, Malle Paris, Liina Vahter, Katrin Gross-Paju, Sulev Haldr. 123I-ADAM SPET imaging of serotonin transporter in patients with epilepsy and comorbid depression. BMC neurology. vol 13. 2014-04-04. PMID:24341899. |
123i-adam spet imaging of serotonin transporter in patients with epilepsy and comorbid depression. |
2014-04-04 |
2023-08-12 |
Not clear |
| Maarika Liik, Malle Paris, Liina Vahter, Katrin Gross-Paju, Sulev Haldr. 123I-ADAM SPET imaging of serotonin transporter in patients with epilepsy and comorbid depression. BMC neurology. vol 13. 2014-04-04. PMID:24341899. |
purpose of the study was to investigate alterations in midbrain serotonin transporter (sert) binding in patients with epilepsy and symptoms of depression compared to patients with epilepsy with no symptoms of depression. |
2014-04-04 |
2023-08-12 |
Not clear |
| Begoña Fernández-Pastor, Jorge E Ortega, J Javier Mean. Involvement of serotonin 5-HT3 receptors in the modulation of noradrenergic transmission by serotonin reuptake inhibitors: a microdialysis study in rat brain. Psychopharmacology. vol 229. issue 2. 2014-03-31. PMID:23636303. |
selective serotonin reuptake inhibitors (ssris), in addition to being able to enhance serotonergic neurotransmission, are able to modulate other brain systems involved in depression. |
2014-03-31 |
2023-08-12 |
rat |
| Jennifer M Spaethling, David Piel, Hannah Dueck, Peter T Buckley, Jacqueline F Morris, Stephen A Fisher, Jaehee Lee, Jai-Yoon Sul, Junhyong Kim, Tamas Bartfai, Sheryl G Beck, James H Eberwin. Serotonergic neuron regulation informed by in vivo single-cell transcriptomics. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 28. issue 2. 2014-03-27. PMID:24192459. |
despite the recognized importance of the dorsal raphe (dr) serotonergic (5-ht) nuclei in the pathophysiology of depression and anxiety, the molecular components/putative drug targets expressed by these neurons are poorly characterized. |
2014-03-27 |
2023-08-12 |
Not clear |
| Jacqueline Hoare, Paul Carey, John A Joska, Henri Carrara, Katherine Sorsdahl, Dan J Stei. Escitalopram treatment of depression in human immunodeficiency virus/acquired immunodeficiency syndrome: a randomized, double-blind, placebo-controlled study. The Journal of nervous and mental disease. vol 202. issue 2. 2014-03-24. PMID:24469525. |
large randomized studies of newer selective serotonin reuptake inhibitors such as escitalopram in the treatment of depression in hiv, examining comparative treatment efficacy and safety, have yet to be done in hiv-positive patients. |
2014-03-24 |
2023-08-12 |
human |
| Hiroto Nakayama, Sumiyo Umeda, Masashi Nibuya, Takeshi Terao, Koichi Nisijima, Soichiro Nomur. Two cases of mild serotonin toxicity via 5-hydroxytryptamine 1A receptor stimulation. Neuropsychiatric disease and treatment. vol 10. 2014-03-14. PMID:24627634. |
recently, the effectiveness of coadministrating 5-ht1a agonistic psychotropics with selective serotonin reuptake inhibitors (ssris) has been reported, and ssris with 5-ht1a agonistic activity have been newly approved in the treatment of depression. |
2014-03-14 |
2023-08-12 |
Not clear |
| Allison C Nugent, Earle E Bain, Paul J Carlson, Alexander Neumeister, Omer Bonne, Richard E Carson, William Eckelman, Peter Herscovitch, Carlos A Zarate, Dennis S Charney, Wayne C Drevet. Reduced post-synaptic serotonin type 1A receptor binding in bipolar depression. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 23. issue 8. 2014-03-13. PMID:23434290. |
reduced post-synaptic serotonin type 1a receptor binding in bipolar depression. |
2014-03-13 |
2023-08-12 |
human |
| Pratibha Gehlawat, Rajiv Gupta, Rajesh Rajput, Deepak Gahlan, Virender Kumar Gehlawa. Diabetes with comorbid depression: role of SSRI in better glycemic control. Asian journal of psychiatry. vol 6. issue 5. 2014-03-11. PMID:24011681. |
treatment of depression with selective serotonin reuptake inhibitors (ssris) may improve glycemic control and may be beneficial for patients with comorbid depression and diabetes. |
2014-03-11 |
2023-08-12 |
Not clear |
| Jinying Zhao, Jack Goldberg, James D Bremner, Viola Vaccarin. Association between promoter methylation of serotonin transporter gene and depressive symptoms: a monozygotic twin study. Psychosomatic medicine. vol 75. issue 6. 2014-03-10. PMID:23766378. |
the serotonin transporter gene (slc6a4) is a key candidate gene for depression. |
2014-03-10 |
2023-08-12 |
Not clear |
| Eco J C de Geus, Christel M Middeldor. Serotonin transporter gene: will epigenetics prove less depressing than genetics? Psychosomatic medicine. vol 75. issue 6. 2014-03-10. PMID:23788696. |
the serotonin transporter gene has been hypothesized to influence, possibly in interaction with environmental factors, the vulnerability for depression. |
2014-03-10 |
2023-08-12 |
Not clear |
| Hersharan Sran, Mysore K Phanis. Confusion after starting citalopram in a renal transplant patient. BMJ case reports. vol 2013. 2014-03-10. PMID:23843413. |
the uk nice (national institute for clinical excellence) guidelines on management of depression in adults recommends use of selective serotonin re-uptake inhibitor (ssri) as a first choice agent. |
2014-03-10 |
2023-08-12 |
Not clear |
| Elizabeth P Hayden, Thomas M Olino, Sara J Bufferd, Anna Miller, Lea R Dougherty, Haroon I Sheikh, Shiva M Singh, Daniel N Klei. The serotonin transporter linked polymorphic region and brain-derived neurotrophic factor valine to methionine at position 66 polymorphisms and maternal history of depression: associations with cognitive vulnerability to depression in childhood. Development and psychopathology. vol 25. issue 3. 2014-03-06. PMID:23880378. |
the serotonin transporter linked polymorphic region and brain-derived neurotrophic factor valine to methionine at position 66 polymorphisms and maternal history of depression: associations with cognitive vulnerability to depression in childhood. |
2014-03-06 |
2023-08-12 |
Not clear |
| Elizabeth P Hayden, Thomas M Olino, Sara J Bufferd, Anna Miller, Lea R Dougherty, Haroon I Sheikh, Shiva M Singh, Daniel N Klei. The serotonin transporter linked polymorphic region and brain-derived neurotrophic factor valine to methionine at position 66 polymorphisms and maternal history of depression: associations with cognitive vulnerability to depression in childhood. Development and psychopathology. vol 25. issue 3. 2014-03-06. PMID:23880378. |
preliminary work indicates that cognitive vulnerability to depression may be associated with variants of the serotonin transporter promoter polymorphism (5-httlpr) and the valine to methionine at position 66 (val66met) polymorphism of the brain-derived neurotrophic factor (bdnf) gene; however, existing reports come from small samples. |
2014-03-06 |
2023-08-12 |
Not clear |
| Adrienne M Banny, Dante Cicchetti, Fred A Rogosch, Assaf Oshri, Nicki R Cric. Vulnerability to depression: a moderated mediation model of the roles of child maltreatment, peer victimization, and serotonin transporter linked polymorphic region genetic variation among children from low socioeconomic status backgrounds. Development and psychopathology. vol 25. issue 3. 2014-03-06. PMID:23880379. |
vulnerability to depression: a moderated mediation model of the roles of child maltreatment, peer victimization, and serotonin transporter linked polymorphic region genetic variation among children from low socioeconomic status backgrounds. |
2014-03-06 |
2023-08-12 |
Not clear |
| Beatriz Castaño-Monsalv. [Antidepressants in epilepsy]. Revista de neurologia. vol 57. issue 3. 2014-03-05. PMID:23881616. |
preferred drugs for treating depression in epilepsy are serotonin reuptake inhibitors. |
2014-03-05 |
2023-08-12 |
Not clear |
| Michel Hamon, Pierre Blie. Monoamine neurocircuitry in depression and strategies for new treatments. Progress in neuro-psychopharmacology & biological psychiatry. vol 45. 2014-02-26. PMID:23602950. |
however, antidepressants acting selectively on only one monoamine, such as selective inhibitors of 5-ht or ne reuptake, alleviate depression symptoms in a limited percentage of patients, and are poorly effective to prevent recurrence. |
2014-02-26 |
2023-08-12 |
Not clear |
| Claudio Solaro, Roberto Bergamaschi, Cristiana Rezzani, Margit Mueller, Erika Trabucco, Valeria Bargiggia, Francesca Dematteis, Alessandra Mattioda, Vincenzo Cimino, Domenico Restivo, Francesco Patti, Paola Cavall. Duloxetine is effective in treating depression in multiple sclerosis patients: an open-label multicenter study. Clinical neuropharmacology. vol 36. issue 4. 2014-02-26. PMID:23783007. |
duloxetine hydrochloride, a dual reuptake inhibitor of serotonin and norepinephrine, was evaluated for its therapeutic efficacy, safety, and tolerability in the treatment of depression in patients with multiple sclerosis (ms). |
2014-02-26 |
2023-08-12 |
Not clear |
| Christopher C Conway, George M Slavich, Constance Hamme. Daily stress reactivity and serotonin transporter gene (5-HTTLPR) variation: internalizing responses to everyday stress as a possible transdiagnostic phenotype. Biology of mood & anxiety disorders. vol 4. issue 1. 2014-02-25. PMID:24461074. |
recent studies examining the interaction between the 5-httlpr locus in the serotonin transporter gene and life stress in predicting depression have yielded equivocal results, leading some researchers to question whether 5-httlpr variation indeed regulates depressive responses to stress. |
2014-02-25 |
2023-08-12 |
Not clear |
| Faruk Ugu. Low-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: three cases. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. vol 26. issue 11. 2014-02-20. PMID:23363390. |
low-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: three cases. |
2014-02-20 |
2023-08-12 |
Not clear |